News & Events

Exonics Therapeutics Raises $40 Million in Series A Financing
NBC’s Sunday Night with Megyn Kelly
Watch Exonics’ scientific founder Dr. Eric Olson discuss the promise of gene editing for Duchenne muscular dystrophy  
The Great Hope / A Doctor’s Dilemma Documentary
Watch Dr. Olson and patient Ben Dupree discuss the potential of Exonics’ gene-editing therapy for Duchenne in this two-part German documentary on gene editing  
A CRISPR/Cas9 Startup Launches on the R&D Frontier, Working on a One-time Fix for Duchenne MD
Endpoints News  
Exonics to Use CRISPR in an Effort to Treat Majority of DMD Boys
Startup Aims to Treat Muscular Dystrophy with CRISPR
MIT Technology Review  
Exonics Therapeutics Launches with Funding from CureDuchenne Ventures to Advance CRISPR/Cas9 Therapy for Duchenne Muscular Dystrophy
Exonics to develop a therapeutic approach to correct underlying genetic mutations in Duchenne, a degenerative genetic disorder without effective treatment options to halt progression of disease.